VISTAGEN THERAPEUTICS, INC. (VTGN) Operating cash flow 2017–2026
VISTAGEN THERAPEUTICS, INC. (VTGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$66.4MFY2026 · since FY2017: -$7.3M → -$66.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$66.4M | -57.8% |
| FY2025 | -$42.1M | -63.1% |
| FY2024 | -$25.8M | +48.1% |
| FY2023 | -$49.7M | -9.9% |
| FY2022 | -$45.3M | -274.8% |
| FY2021 | -$12.1M | +23.4% |
| FY2020 | -$15.8M | -8.5% |
| FY2019 | -$14.5M | -60.4% |
| FY2018 | -$9.1M | -24.7% |
| FY2017 | -$7.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice